|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0014582,
umls-concept:C0016360,
umls-concept:C0023981,
umls-concept:C0040808,
umls-concept:C0045093,
umls-concept:C0205088,
umls-concept:C0281361,
umls-concept:C0332283,
umls-concept:C1274040,
umls-concept:C1511562,
umls-concept:C1522449
|
|
pubmed:issue |
2-3
|
|
pubmed:dateCreated |
2005-8-9
|
|
pubmed:abstractText |
Postoperative management of patients with pancreatic adenocarcinoma (PA) is controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2005 S. Karger AG, Basel.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
239-45
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:16015040-Adenocarcinoma,
pubmed-meshheading:16015040-Adult,
pubmed-meshheading:16015040-Aged,
pubmed-meshheading:16015040-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16015040-Chemotherapy, Adjuvant,
pubmed-meshheading:16015040-Cisplatin,
pubmed-meshheading:16015040-Deoxycytidine,
pubmed-meshheading:16015040-Disease-Free Survival,
pubmed-meshheading:16015040-Epirubicin,
pubmed-meshheading:16015040-Feasibility Studies,
pubmed-meshheading:16015040-Female,
pubmed-meshheading:16015040-Fluorouracil,
pubmed-meshheading:16015040-Humans,
pubmed-meshheading:16015040-Male,
pubmed-meshheading:16015040-Middle Aged,
pubmed-meshheading:16015040-Pilot Projects,
pubmed-meshheading:16015040-Prospective Studies,
pubmed-meshheading:16015040-Radiotherapy, Adjuvant,
pubmed-meshheading:16015040-Survival Analysis,
pubmed-meshheading:16015040-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma.
|
|
pubmed:affiliation |
Department of Radiochemotherapy, S. Raffaele H. Scientific Institute, Milan, Italy. reni.michele@hsr.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
